Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Net Income (2009 - 2026)

Charles River Laboratories International (CRL) posted Net Income of -$760000.0 for Q2 2026, up 94.87% on a QoQ basis from -$14.8 million in Q1 2026, and down 101.44% year-over-year from $52.7 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Net Income (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Net Income for 18 years, with the latest figure at -$760000.0 in Q2 2026.

  • On a quarterly basis, Net Income fell 101.44% year-over-year to -$760000.0 in Q2 2026; TTM through Jun 2026 was -$236.3 million, a 264.2% decrease from a year earlier, with the FY2025 full-year figure at -$142.2 million, down 662.11% from the prior year.
  • Net Income was -$760000.0 for Q2 2026 at Charles River Laboratories International, up from -$14.8 million in the prior quarter.
  • The five-year high for Net Income was $189.1 million in Q4 2022, with the low at -$276.3 million in Q4 2025.
  • Average Net Income over 5 years is $46.7 million, with a median of $81.3 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Net Income soared 48.94% in 2022, then tumbled 213.12% in 2024.
  • Over 5 years, Net Income stood at $189.1 million in 2022, then slipped by 0.08% to $189.0 million in 2023, then sank by 213.12% to -$213.7 million in 2024, then slipped by 29.26% to -$276.3 million in 2025, then jumped by 99.72% to -$760000.0 in 2026.
  • The last three Net Income figures came in at -$760000.0 (Q2 2026), -$14.8 million (Q1 2026), and -$276.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 241.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 121.36 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 111.81 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -760,000.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -13.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -46.71 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -426,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -4.36 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -760,000.00
Mar 28, 2026 -14.80 Mn
Dec 27, 2025 -276.29 Mn
Sep 27, 2025 55.56 Mn
Jun 28, 2025 52.69 Mn
Mar 29, 2025 25.88 Mn
Dec 28, 2024 -213.75 Mn
Sep 28, 2024 70.30 Mn
Jun 29, 2024 94.26 Mn
Mar 30, 2024 74.48 Mn
Dec 30, 2023 188.95 Mn
Sep 30, 2023 88.02 Mn
Jul 1, 2023 99.44 Mn
Apr 1, 2023 103.95 Mn
Dec 31, 2022 189.11 Mn
Sep 24, 2022 97.61 Mn
Jun 25, 2022 110.66 Mn
Mar 26, 2022 95.23 Mn
Dec 25, 2021 139.83 Mn
Sep 25, 2021 105.16 Mn